Syntimmune is a clinical-stage biotechnology company developing differentiated drug candidates in a wide range of autoimmune diseases. Drawing on the pioneering...
View Top Employees from SyntimmuneWebsite | http://www.syntimmune.com |
Revenue | $11.4 million |
Funding | $118 million |
Employees | 9 (0 on RocketReach) |
Founded | 2013 |
Address | 116 Huntington Ave., Ste. 301, Boston, Massachusetts 02116, US |
Phone | (617) 206-4220 |
Technologies | |
Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Emergency Medicine, Health Care, Medical, Pharmaceutical |
Competitors | Adimab, Momenta Pharmaceuticals, PTC Therapeutics, Inc., Xencor |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Syntimmune employee's phone or email?
The Syntimmune annual revenue was $11.4 million in 2023.
Syntimmune is based in Boston, Massachusetts.
The NAICS codes for Syntimmune are [3254, 325, 32].
The SIC codes for Syntimmune are [283, 28].